resources

Hester Biosciences Ltd.

NSE: HESTERBIO

BSE: 524669

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

2,347.20-91.7 (-3.76%)

26 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Hester Biosciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	8Feb 16Jun 17Aug 9Nov	23Aug 7Nov	2Feb 22May 16Aug 9Nov	5Feb 14May 5Aug 30Oct	1Feb 12May 4Aug 14Nov	2Feb 18May 1Aug
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Hester Biosciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Postal Ballot4 Aug 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice
Analyst / Investor Meet1 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings Conference Call held on 30 July 2026
General31 Jul 2026
Launch Of Interactive Microsite Of 39Th Annual Report FY 2025-26
Launch of Interactive Microsite of 39th Annual Report FY 2025-26
Newspaper Publication31 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Clippings of Q1 FY27 Financial Results publication
Analyst / Investor Meet30 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the Earnings Conference Call held on 30 July 2026
Press Release / Media Release30 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
20260730 Q1 FY27 Press Release
Outcome of Board Meeting30 Jul 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 30 July 2026
Outcome of Board Meeting held today
Analyst / Investor Meet25 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call schedule to be held on 30 July 2026 at 2:00 p.m. (IST) post the publication of financial results
General25 Jul 2026
Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
We wish to inform that NSE and BSE has issued their NOC for the re-classification application filed on 19 May 2026.The copies of NOC enclosed herewith.
Board Meeting23 Jul 2026
Board Meeting Intimation for Financial Results
Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the unaudited standalone ....
AGM21 Jul 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of 39th Annual General Meeting and Scrutiniser Report
AGM21 Jul 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 39th Annual General Meeting, Voting Results and Scrutinizer Report of the Company
General9 Jul 2026
Disclosure Under Regulation 30 Of The SEBI Listing Regulations- Sale Of Equity Investment In Texas Lifesciences Private Limited
Disclosure under Regulation 30 of the SEBI Listing Regulations - Sale of Equity Investment in Texas Lifesciences Private Limited
Newspaper Publication9 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication dated 9 July 2026 for the Transfer of Equity Shares of the Company to IEPF on compliance of IEPF Rules
Newspaper Publication9 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper clipping for the publication dated 9 July 2026 for Corrigendum to the Notice convening 39th Annual General Meeting
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Confirmation Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30 June 2026
AGM8 Jul 2026
Corrigendum To The Notice Convening 39Th Annual General Meeting
Corrigendum to the Notice convening 39th Annual General Meeting of the Company
Closure of Trading Window26 Jun 2026
Closure of Trading Window
Closure of Trading Window
Newspaper Publication19 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of newspaper advertisement for 39th Annual General Meeting
Business Responsibility and Sustainability Reporting (BRSR)18 Jun 2026
Business Responsibility and Sustainability Reporting (BRSR)
FY 2025-26 Business Responsibility and Sustainability Report

Frequently Asked Questions

Where can I download the annual report of Hester Biosciences Ltd.?

Annual reports of Hester Biosciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Hester Biosciences Ltd.?

Quarterly earnings results and presentations of Hester Biosciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Hester Biosciences Ltd. publish earnings call transcripts?

Earnings call transcripts of Hester Biosciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Hester Biosciences Ltd.?

Investor presentations and annual day presentations of Hester Biosciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Hester Biosciences Ltd.?

Corporate announcements and regulatory filings of Hester Biosciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Hester Biosciences Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Hester Biosciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Hester Biosciences Ltd.?

The ISIN (International Securities Identification Number) of Hester Biosciences Ltd. is INE782E01017. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Hester Biosciences Ltd. listed?

Hester Biosciences Ltd. is listed on NSE and BSE. The NSE symbol is HESTERBIO and the BSE code is -.

Where can I find the shareholding pattern of Hester Biosciences Ltd.?

The quarterly shareholding pattern of Hester Biosciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Hester Biosciences Ltd. on Sharpely?

Share price data for Hester Biosciences Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.